DIFFICIL-S® has been independently tested by NHS laboratories at a dilution rate of 1:400 to give at least a 5 log reduction of 99.999% in Clostridium difficile (including spores), MRSA, Listeria, E.coli, Salmonella, Pseudomonas, Mycobacteria (tubercle bacilli), Norovirus and other pathogens.

OUR COMPANY

DIFFICIL-S® is part of the Cleankill range of infection control products manufactured by Clinimax Ltd.

Clinimax Ltd is a privately owned British company specializing in the research, development and manufacture of innovative infection control products for use by the healthcare profession.

Bio-security is of ever increasing importance in today’s world of new and potentially fatal pathogens. Micro-organisms are continually evolving and developing resistance to current drugs and disinfectants so that the emergence of new disease strains is a constant threat.

Our mission at Clinimax is to remain at the forefront of bio-security technology by continual research and development to improve our wide range of infection control products under the Cleankill branding.

All Cleankill products have been formulated exclusively in our own laboratories and have been independently tested and given a 5 log reduction against all known pathogens by University Hospital Birmingham NHS Foundation Trust research laboratories.

Clinimax Ltd is a division of Animax Ltd who have been operational since 1982 and are licensed for the research, development and production of veterinary medicines.

Contact us at Clinimax/Difficil-S

For more information on DIFFICIL-S® please contact us at:-
Clinimax Ltd. Shepherds Grove West, Stanton
Bury St. Edmunds, Suffolk IP31 2AR England

Tel: +44 (0)1359 252181 Fax: +44 (0)1359 252182
Email: info@difficil-s.com